The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The companies will work with investigators to share the results with the scientific community
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Subscribe To Our Newsletter & Stay Updated
